What a session it was for a certain Colorado-based %Healthcare company after it was announced that it received the US Food ...

“These are scams,” said Kenny Biddle, the chief investigator for the Center of Inquiry, an organization devoted to defending ...

The S&P 500 ended 0.3% lower on Wednesday, Sept. 18, 2024, as the Federal Reserve announced its first interest-rate cut since ...

In the release announcing its Watch Series 10’s availability, Apple refers to the device’s “refined” design. It’s an accurate ...

Vivos Therapeutics is a pioneering medical device and technology company focused on addressing sleep-related breathing disorders (SRBDs), particularly obstructive sleep apnea (OSA). Their flagship ...

Vivos Therapeutics (VVOS) stock gains as company receives FDA clearance for its DNA appliance to treat obstructive sleep ...

Vivos Therapeutics (NASDAQ: VVOS), a leading medical-device and technology company specializing in the development and commercialization of highly effective proprietary treatments for sleep-related ...

The FDA has granted 510(k) clearance to Vivos Therapeutics' DNA oral appliance for treating moderate to severe obstructive ...

said this is believed to be the first ever FDA clearance to treat moderate to severe obstructive sleep apnea and snoring in children. The 510(k) clearance allows medical devices to enter the U.S.

Vivos is poised to disrupt the very significant pediatric obstructive sleep apnea (OSA) market with new FDA clearance and new strategic marketing ...

The iPhone 16's headliner features are Apple Intelligence, which will be rolled out next month, and its camera system.

(RTTNews) - Vivos Therapeutics, Inc. (VVOS) announced on Wednesday that it has obtained 510(k) clearance from the FDA for its DNA oral medical device aimed at treating moderate to severe obstructive ...